|
| 7:45 - 8:15 am: | |
Continental Breakfast and Registration |
|
|
8:15 - 8:30 am: | |
Welcome - Faramarz Ismail-Beigi, MD PhD, Chair, Department
|
| | | Clinical and Molecular Endocrinology, Case School of Medicine, and |
| | | Co-Director, Cleveland Diabetes Center; |
| | | Mr. Richard Dietrich; and Philip Goldberg, MD, Chairman, |
| | | Board of Directors, Diabetes Association of Greater Cleveland |
|
| 8:30 - 8:45 am: | |
Opening Address - Pamela B. Davis, MD PhD, |
| | | Interim Dean, Case School of Medicine |
|
| 8:45 - 9:45 am: | |
Keynote Address - “The Importance of Supporting Clinical Trial Research in the Academy” |
| | | David Nathan, MD, Professor of Medicine, Harvard Medical School, Director, Diabetes Center and General Clinical Research Center,
Massachusetts General Hospital
|
|
| 9:45 - 10:30 am: | |
Plenary speaker - "The Impact of Diabetes Prevention on CVD Risk" |
| | | Robert Ratner, MD, Professor of Medicine, Georgetown University Medical School and Vice-President for Scientific Affairs for the MedStar Research Institute |
|
| 10:30 - 10:45 am: | |
Break |
|
| 10:45 - 11:30 pm: | |
Plenary Speaker - "Etiology of Diabetes in Pima Indians" |
| | | Clifton Bogardus III, MD, Chief, Phoenix Epidemiology and Clinical Research Branch, NIDDK, NIH |
|
| 11:30 - 12:15 pm: | |
"Clinical Trials in Cleveland - ACCORD, DCCT/EDIC, BARI2D"
|
| | | Saul Genuth, MD, Case School of Medicine |
|
| 12:15 - 1:00 pm: | |
Research Updates - Faramarz Ismail-Beigi, MD, PhD |
| | | Buffet Lunch |
|
| 1:00 - 1:45 pm: | |
Poster viewing & presentations |
|
| 1:45 - 2:30 pm: | |
“Traditional and Novel Risk Factors for Coronary Heart Disease: |
| | | Past, Present and Future Trials in Diabetes Mellitus” |
| | | Byron J. Hoogwerf, MD, Cleveland Clinic |
|
| 2:30 - 3:30 pm: | |
Local Research Showcase |
| | | Firouz Daneshgari, MD |
| | | Susanne Mohr, PhD |
| | | Stephen Previs, PhD |
|
| 3:30 - 3:45 pm: | |
Closing Remarks - Faramarz Ismail-Beigi, MD, PhD |